485 related articles for article (PubMed ID: 34209679)
1. New Angiogenic Regulators Produced by TAMs: Perspective for Targeting Tumor Angiogenesis.
Larionova I; Kazakova E; Gerashchenko T; Kzhyshkowska J
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34209679
[TBL] [Abstract][Full Text] [Related]
2. Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors.
Kes MMG; Van den Bossche J; Griffioen AW; Huijbers EJM
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188427. PubMed ID: 32961257
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of the vascular endothelial growth factor and semaphorin ligand-receptor families in prostate cancer metastasis.
Bender RJ; Mac Gabhann F
BMC Syst Biol; 2015 Sep; 9():55. PubMed ID: 26341082
[TBL] [Abstract][Full Text] [Related]
4. CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer.
Lin L; Chen YS; Yao YD; Chen JQ; Chen JN; Huang SY; Zeng YJ; Yao HR; Zeng SH; Fu YS; Song EW
Oncotarget; 2015 Oct; 6(33):34758-73. PubMed ID: 26416449
[TBL] [Abstract][Full Text] [Related]
5. YKL-39 as a Potential New Target for Anti-Angiogenic Therapy in Cancer.
Kzhyshkowska J; Larionova I; Liu T
Front Immunol; 2019; 10():2930. PubMed ID: 32038607
[TBL] [Abstract][Full Text] [Related]
6. The role of tumor-associated macrophages in tumor vascularization.
Guo C; Buranych A; Sarkar D; Fisher PB; Wang XY
Vasc Cell; 2013 Dec; 5(1):20. PubMed ID: 24314323
[TBL] [Abstract][Full Text] [Related]
7. Resistance Mechanisms to Anti-angiogenic Therapies in Cancer.
Haibe Y; Kreidieh M; El Hajj H; Khalifeh I; Mukherji D; Temraz S; Shamseddine A
Front Oncol; 2020; 10():221. PubMed ID: 32175278
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via α9β1 integrin.
Kale S; Raja R; Thorat D; Soundararajan G; Patil TV; Kundu GC
Oncogene; 2014 May; 33(18):2295-306. PubMed ID: 23728342
[TBL] [Abstract][Full Text] [Related]
9. Novel Angiogenic Regulators and Anti-Angiogenesis Drugs Targeting Angiogenesis Signaling Pathways: Perspectives for Targeting Angiogenesis in Lung Cancer.
Li Y; Lin M; Wang S; Cao B; Li C; Li G
Front Oncol; 2022; 12():842960. PubMed ID: 35372042
[TBL] [Abstract][Full Text] [Related]
10. The Role of Osteopontin in Tumor Progression Through Tumor-Associated Macrophages.
Tan Y; Zhao L; Yang YG; Liu W
Front Oncol; 2022; 12():953283. PubMed ID: 35898884
[TBL] [Abstract][Full Text] [Related]
11. Curcumin suppresses breast tumor angiogenesis by abrogating osteopontin-induced VEGF expression.
Chakraborty G; Jain S; Kale S; Raja R; Kumar S; Mishra R; Kundu GC
Mol Med Rep; 2008; 1(5):641-6. PubMed ID: 21479462
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients.
Hwang I; Kim JW; Ylaya K; Chung EJ; Kitano H; Perry C; Hanaoka J; Fukuoka J; Chung JY; Hewitt SM
J Transl Med; 2020 Nov; 18(1):443. PubMed ID: 33228719
[TBL] [Abstract][Full Text] [Related]
13. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
Shinkaruk S; Bayle M; Laïn G; Déléris G
Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
[TBL] [Abstract][Full Text] [Related]
15. Broad targeting of angiogenesis for cancer prevention and therapy.
Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD
Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295
[TBL] [Abstract][Full Text] [Related]
16. Angiopoietin inhibitors: A review on targeting tumor angiogenesis.
Parmar D; Apte M
Eur J Pharmacol; 2021 May; 899():174021. PubMed ID: 33741382
[TBL] [Abstract][Full Text] [Related]
17. Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages.
Donzelli S; Milano E; Pruszko M; Sacconi A; Masciarelli S; Iosue I; Melucci E; Gallo E; Terrenato I; Mottolese M; Zylicz M; Zylicz A; Fazi F; Blandino G; Fontemaggi G
Breast Cancer Res; 2018 Jun; 20(1):59. PubMed ID: 29921315
[TBL] [Abstract][Full Text] [Related]
18. Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment.
Deryugina EI; Zajac E; Juncker-Jensen A; Kupriyanova TA; Welter L; Quigley JP
Neoplasia; 2014 Oct; 16(10):771-88. PubMed ID: 25379015
[TBL] [Abstract][Full Text] [Related]
19. Tumour-associated macrophages correlate with microvascular bed extension in colorectal cancer patients.
Marech I; Ammendola M; Sacco R; Sammarco G; Zuccalà V; Zizzo N; Leporini C; Luposella M; Patruno R; Filippelli G; Russo E; Porcelli M; Gadaleta CD; De Sarro G; Ranieri G
J Cell Mol Med; 2016 Jul; 20(7):1373-80. PubMed ID: 27105577
[TBL] [Abstract][Full Text] [Related]
20. The contribution of tumor-associated macrophages in glioma neo-angiogenesis and implications for anti-angiogenic strategies.
Zhu C; Kros JM; Cheng C; Mustafa D
Neuro Oncol; 2017 Oct; 19(11):1435-1446. PubMed ID: 28575312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
